At Johnson & Johnson, I’m the Financial Controller, Australia & New Zealand/Transformation Lead for Medical Devices & Technology. I led finance readiness for the carveout of a $250M+ business, spanning working capital, the opening balance sheet, ERP and operational cutover through go-live and hypercare.
I also strengthened the control environment and led a comprehensive ANZ internal audit, with no significant or major control deficiencies identified. By resolving return-to-source constraints, I avoided more than $2M in inventory write-off.
Previously, as Senior Finance Manager, Regional Strategy Organisation at Johnson & Johnson’s Janssen Pharmaceutical business, I partnered with regional executives on portfolio strategy, investment and launches across five therapy portfolios. I served as the final finance decision gate before C-suite approval, shaping choices across a US$6B+ portfolio and 20+ markets.
In FP&A management roles, I led the first deployment of an FP&A Centre of Excellence and a geographically dispersed team of six. Standardisation and process simplification improved forecast accuracy to 95% and reduced reporting cycle time by 30%; earlier commercial finance roles included implementing TM1 and Integrated Business Planning.

